Seres Therapeutics
MCRB
#10246
Rank
C$4.51 M
Marketcap
$0.52
Share price
1.11%
Change (1 day)
-58.36%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.53

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.55. In 2022 the company made an earnings per share (EPS) of -$3.24 a decrease over its 2021 EPS that were of -$1.01.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-52.75%
2022-$3.24220.55%
2021-$1.01-34.23%
2020-$1.54-15.27%
2019-$1.81-46.09%
2018-$3.369.95%
2017-$3.06-3.49%
2016-$3.17-10.19%
2015-$3.53321.85%
2014-$0.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.96 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.46 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA